Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue.

skip to content

Country Selector

Based on your location

Europe

North America

Latin America

Asia-Pacific

Healthcare Sector Verification

This section contains information intended for healthcare professionals.

Please confirm that you are affiliated with a healthcare organization.

The importance of testing anti-dsDNA, anti-nucleosome and anti-C1q antibodies in patients with systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease characterized by multisystem clinical presentation and serologic findings of various antibodies.

Published: 13.11.2026 | Modified: 13.11.2026
  • Anti-dsDNA and anti-nucleosome have high specificity and positive predictive value for systemic lupus erythematosus (SLE) diagnosis.
  • Anti-nucleosome and anti-C1q antibodies show an association with SLE and lupus nephritis activity, suggesting their potential usefulness in making predictions about lupus nephritis and assessment of disease activity.
Anti-dsDNA_Publication

Tests associated with this resource

Related instruments

Discover more resources on Connective Tissue Diseases

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.